Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

• Auteurs principaux: Josephine A. Adattini (Auteur), Annette S. Gross (Auteur), Nicole Wong Doo (Auteur), Andrew J. McLachlan (Auteur)
• Format: Livre
• Publié: Wiley, 2022-10-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Tyrosine kinase inhibitors (TKI) have revolutionized the treatment of chronic myeloid leukemia (CML), but patients still experience treatment‐limiting toxicities or therapeutic failure. To investigate the real‐world use and outcomes of imatinib in patients with CML in Australia, a retrospec...